About 80 percent of the $200 billion global biopharmaceuticals market covers the manufacture of early clinical trials materials in single-use systems (SUS). The use of such systems for commercial-scale manufacture of biopharmaceutical systems is rapidly increasing, being estimated to have a value of about $1.2 billion in 2015 and growing at a compound annual growth…